Templates detected with the intronic primer were induced in macrophages by LPS, PMA, and CSF-1, suggesting that each of the agents caused a shift from full-length c-Jins mRNA production to production of unspliced, truncated transcripts. The c-Jins promoter functioned constitutively in the RAW264 macrophage cell line, the B-cell line MOPC.31C, and several nonhematopoietic cell lines. Macrophage-specific expression and responsiveness to selective repression by LPS and PMA was achieved by the incorporation of intron 2 into the c-Jins promoter-reporter construct. The results suggest that expression of the c-fins gene in macrophages is controlled by sequences in intron 2 that act by regulating transcription elongation.
Macrophage colony-stimulating factor 1 (CSF-1) promotes the survival, proliferation, and differentiation of cells of the mononuclear phagocyte series (29) . Its biological activities are mediated by binding to a plasma membrane receptor, the product of the c-fins proto-oncogene, which is a liganddependent protein tyrosine kinase (24) . Expression of c-fins mRNA and CSF-1 binding activity is largely restricted to mononuclear phagocytes and placental trophoblasts (24) . Although there has been considerable progress in understanding tissue-specific gene expression in other hematopoietic cell lineages, macrophage differentiation remains poorly understood at the level of gene transcription. The most extensive studies have been of the lysozyme gene in chickens, which is controlled by a complex interaction between macrophage-specific enhancer elements and silencers that restrict gene expression in nonmacrophages (10) . The paucity of information about macrophage-specific gene expression has been attributed to the difficulty of obtaining high transfection efficiencies with primary mammalian macrophages or myelomonocytic cell lines (25) , a technical obstacle that we have recently overcome in a study of the constitutive elements controlling the expression of the urokinase plasminogen activator gene in macrophages (3) . The limited literature on macrophage-specific gene expression has been largely dependent upon the use of transgenic animals (2, 25) , which places limitations on detailed analysis of cis-acting sequences. Preliminary characterization of the * Corresponding author.
human gene encoding c-fins revealed that in the two cell types that express the gene, trophoblasts and macrophages, transcription is initiated from two separate promoters, separated by a 25-kb intron (30) . A limited analysis of transcriptional regulation of the two promoters in human cell lines (20) suggested that a 550-bp segment flanking exon 2 can direct macrophage-specific expression of a reporter gene. In this report, we show that the murine c-fins gene contains a constitutive promoter and that production of full-length mRNA is controlled by sequences in intron 2 that regulate transcript elongation.
MATERUILS AND METHODS
Cell lines and cell culture. The cell lines RAW264, Lewis lung carcinoma (LLC1 or LL/2), L929 (fibrosarcoma), BALB/3T12-3 (embryonic fibroblasts), BALB/c 10ME HD.A 5R.1 (methylcholanthrene-transformed fibroblasts), BALB/c Cl.7 (embryonic fibroblasts), and MOPC.31C were obtained from the American Type Culture Collection. They were maintained in RPMI 1640 plus 10% fetal bovine serum. Primary bone marrow-derived macrophages (BMDM) were produced by cultivation of murine femoral bone marrow cells in recombinant human CSF-1 (a gift from Chiron Corp.) as described previously (14, 15) . Lipopolysaccharide (LPS; Re595 from Salmonella minnesota) and phorbol myristate acetate (PMA) were obtained from Sigma.
Mouse c-fins genomic clone isolation and plasmid construction. A mouse genomic DNA library from the A17 murine T-cell lymphoma cell line in XEMBL3A (a gift from Mark 3192 XIE ET AL.
Hogarth) was screened with a 5' restriction fragment of the murine c-fins cDNA (21) kindly provided by Larry Rohrschneider. A clone containing a 14-kb Sall insert was isolated, the restriction map of which was consistent with the identity of this clone as the Sall genomic DNA fragment which encompasses the 5' end of the murine c-fins gene (9) .
A 7-kb ApaI fragment bracketing the 5' end of the gene was subcloned into pBluescript (Stratagene) to yield pXYfinsl, and subfragments were sequenced by the dideoxy-chain termination method, using a Pharmacia T7 polymerase kit and double-stranded plasmid templates. The 3' ApaI site in this clone is at position 134 in the murine cDNA sequence (21) . The restriction map of this fragment is presented in Fig.   7 , in the context of the analysis of reporter constructs.
Chloramphenicol acetyltransferase (CAT) reporter constructs were generated by subcloning the desired restriction fragments from the ApaI genomic DNA fragment in pBluescript into the multiple cloning site of the vector pCAT-Basic (Promega). The positive control vector pH,BAPr-CAT, a gift from Peter Gunning, contains a 4.3-kb EcoRI-AluI fragment of the human P-actin promoter linked to the CAT gene. An additional set of reporter constructs was constructed in the luciferase reporter gene plasmid pGL2-Basic (Promega). This vector has the advantage of both increased sensitivity and a low nonspecific background due to the presence of a polyadenylation signal, to prevent read-through transcripts from the vector, placed upstream of the multiple cloning site. The desired restriction fragments from the ApaI genomic DNA clone were also cloned into the multiple cloning site of this vector. In the case of the intron-containing c-fins plasmid, pGL6.7flns, the c-fins genomic DNA was removed from pXYflnsl as an SpeI fragment and inserted into the same site in pGL2-Basic. The 5' SpeI site in this case is approximately 50 bp into the c-fins promoter sequence, while the 3' SpeI site is in the pBluescript multiple cloning site. Plasmid pGL2-Control, containing the simian virus 40 (SV40) early promoter and enhancer, was used in some experiments. Because this vector displayed some apparent tissue specificity, another control vector was produced by inserting the EcoRI-AluI fragment of the human ,B-actin promoter (see above) into the multiple cloning site of pGL2-Basic. This plasmid is referred to as pGL-HPAPr.
RNA extraction, RNase protection, and primer extension analysis. RNA was isolated by the method of Evans et al. (8) . Briefly, cells were lysed by shearing in 8 M guanidine-HCl-0.3 M sodium acetate-1% sarcosyl. After centrifugation, the supernatant was ethanol precipitated, and the pellet was suspended in 8 M guanidine-0.3 M sodium acetate, reprecipitated, washed twice with 70% ethanol, and dissolved in Tri §-EDTA buffer. Primer extension was performed exactly as described by Sambrook et al. (22) except that N-2-hydrdxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES) buffer was substituted for piperazine-N,N'-bis(2-ethanesulfonic acid) (PIPES 
..AG c-fins promoters of the mouse and human genes contain several sites similar to the binding sites of the ubiquitous CCAAT box-binding proteins ( Fig. 1 ), but none fits perfectly the consensus sequence for CBP-1, CBP-2, or NF-1 (6). The c-fns promoters in both species contain multiple polypurine and polypyrimidine strings containing the 5'-GGAA-3' recognition site of the ets family of transcription factors (31), including two copies in each species of the PU box (5'-GAGGAA-3'), the binding site for the transcription factor PU.1, which is restricted to B cells and macrophages (17) . One other feature of interest is the multiple APl-like (5'-TGACTCA-3') and AP2-like (5'-CCCAGGC-3') sites in both species, both of which might confer phorbol ester responsiveness (5) . Finally, the murine c-Jins promoter contains the TATA-like sequence 5'-TTATTTfATGC-3' at -252 ( Fig. 1 5' end of exon 3, was used, extension products were generated from primary macrophage or RAW264 RNA ( (primer B), no effect of CSF-1, LPS, or PMA on the yield of primer extension products was observed. Conversely, when primer E (at the beginning of exon 3) was used, there was a clear decrease in the yield of all of the extension products in response to each of the three agonists. The magnitude of this decrease is indicated by quantitation of the total radioactivity incorporated into extension products with use of an AMBIS Radioanalyser (Fig. 3) . The same pattern of results was obtained with use of the three stimuli on RAW264 cells (not shown).
If there is a block to transcription elongation prior to the beginning of exon 3 in nonmacrophages and in macrophages treated with agonists, it should be possible to detect transcripts containing intron 2. To investigate this possibility, the sequence of the mouse gene early in intron 2 was ascertained. Sequencing of this region was particularly difficult because of extensive secondary structure which was not resolved by using Taq polymerase at higher temperature. Readable sequence required the use of deaza-dGTP and 8 M urea-30% formaldehyde denaturing gels. Alignment of the mouse and human sequences in this region reveals low-level homology (Fig. 4) . Regions of transcription attenuation in eukaryotic genes have commonly been associated with GC-VOL. 13 rich elements containing dyad symmetry which might potentially form stable stem-loops in transcribed RNA or singlestranded DNA (27) . The intronic sequences of both the mouse and human c-fins genes contain extended GC-rich repeats. Potential stem-loops formed by these repeats are shown in Fig. 4 and compared with the TAR region of the human immunodeficiency virus, a known stable secondary structure (27) . Primer extension was repeated by using a primer (primer F) based upon the intron 2 sequence around the predicted stem loop in Fig. 4 . Identical primer extension products were detected in all cell types examined, except BMDM starved of CSF-1 to maximally up-regulate c-fins mRNA (Fig. 5) . In these cells, the level of intron-containing RNA was much lower but was increased by each of the agonists, LPS, PMA, and CSF-1, shown to down-regulate full length c-fns mRNA (Fig. 3) . The data suggest that the level of intron-containing transcripts varies inversely with the level of full-length c-fns transcripts and are consistent with the existence of a site of selective transcription elongation within intron 2.
In an attempt to identify the sites of transcription attenuation in intron 2 and to independently validate the primer extension results, we performed RNase protection studies. c-fins genomic DNA extending from -203 to +210 was cloned into pBluescript, and a radiolabeled RNA probe was generated by using T3 RNA polymerase. Both BMDM and RAW264 RNA protected the labeled probe against RNase digestion, producing multiple protected bands (Fig. 6A) . The position of these bands relative to the splice donor site at the end of exon 2 correlated precisely with the clustered transcription start sites identified by primer extension in Fig. 2 . RNA obtained from BMDM treated with CSF-1, LPS, or PMA was less effective in producing all of the protected bands, indicating that the abundance of each of the bands correlates with the abundance of full-length c-fins mRNA.
When RNA from L929, Lewis lung carcinoma, or MOPC.31C cells was used, no protected bands were detected even when the amount of RNA added was increased to 50 p,g and the autoradiographs were exposed for a prolonged period (data not shown).
Because of the extensive GC-rich inverted repeats in exon 2 and the beginning of intron 2, we reasoned that internal stem loops in the intron-containing truncated transcripts could be interfering with efficient hybridization. To eliminate these potential structures from the probe, we prepared a new probe template by subcloning the 5' end of murine c-fins cDNA (21) They were then incubated for 4 h with CSF-1 (1,000 U/ml), LPS (100 ng/ml), or PMA (10-v M) prior to RNA isolation. RNA (50 ,ug) from each treatment was incubated with radiolabeled primer B (end of exon 2) or primer E (beginning of exon 3) and extended with reverse transcriptase. The extension products were separated on a sequencing gel in parallel with a sequencing reaction. Quantitation was achieved by scanning the entire gel with an AMBIS Radioanalyser and counting the total radioactivity in the extension products in each lane. The results expressed as total counts per minute are displayed below each lane.
as a probe, RNA from BMDM or RAW264 cells generated the expected 186-base protected band, but it was still impossible to detect any protected bands when nonmacrophage RNA was used (data not shown).
The only way to eliminating secondary structures from the transcripts is to denature and immobilize them. Accordingly, the 5' c-fins antisense RNA probe was used in a dot blot hybridization on macrophage and nonmacrophage RNA bound to nitrocellulose membranes. The result (Fig. 6B) indicates that macrophages and nonmacrophages do indeed contain approximately equal levels of transcripts that hybridize to the 5' end of c-fins. Furthermore, as suggested by the primer extension data in Fig. 3 , CSF-1, LPS, and PMA had no significant effect on the abundance of transcripts detected with the 5' c-fins probe. The reasons why short transcripts cannot be detected in nonmacrophages by RNase protection are considered in Discussion. Transient transfection analysis. The expression of similar levels of presumptive short c-fins transcripts in macrophages and nonmacrophages implies that the c-fins promoter is not tissue specific. Promoter specificity was assayed directly by transient transfection using reporter gene constructs linking the CAT gene to the c-fins promoter. Because of the heterogeneity of transcription start sites identified in Fig. 2 , most of the constructs were designed to include the entire 5' untranslated region of c-fins by retaining the c-fins initiation codon. In the first experiment, a series of CAT reporter construct deletions was transfected into RAW264 cells. The most extensive construct contained ca. 3.5 kb of 5' flanking sequence. Sequential deletion of the 5' flanking sequence produced little alteration of the level of reporter gene expression (Fig. 7a) . Even deletion to -200 reduced but did not abolish the constitutive activity in RAW264 cells. 3' truncation of the promoter to -63 ( Fig. 1) (which means that the CAT rather than the c-fins initiation codon is used) also had little effect. This construct is comparable to the human c-fins promoter constructs used by Roberts et al. (20) Fig. 3 . RNA (50 p.g) was hybridized to radiolabeled primer F, which is based upon the sequence in the vicinity of the potential stem-loop early in murine c-fins intron 2 (Fig. 4) , and extended by using reverse transcriptase. The extension products were separated on a sequencing gel in parallel with a sequencing ladder generated by using the same primer. Quantitation was achieved by scanning the entire gel with an AMBIS Radioanalyser and counting the total radioactivity in the extension products in each lane. The results (expressed as total counts per minute) are displayed below each lane.
CAT gene was fused at -57. Treatment of the RAW264 cells transfected with the reporter constructs with PMA had no effect on CAT activity (Fig. 7a) . The activities of long (pFMS3.5CAT) and short (pFMSO.3CAT) c-fins reporter constructs were also tested in nonmacrophages, using a ,-actin promoter-CAT construct as a transfection control. The relative activities of the two c-fins constructs did not distinguish RAW264 cells from the B-cell line MOPC.31C or any of the nonhematopoietic murine tumor cell lines tested (Fig. 8) .
To address the role of intron 2 in generating tissue specificity, the c-fins genomic DNA fragments were transferred to the luciferase reporter construct, pGL2-Basic. Apart from the availability of a more convenient set of Figure 9A compares the activities of three constructs, a 0.3-kb c-fins promoter, a 3.5-kb c-fins promoter, and a minigene construct (pGL6.7,fns) containing the 3.5-kb 5' flanking sequence plus the whole of intron 2 and the beginning of exon 3. The results obtained with the first two constructs confirm those obtained with the CAT vectors; the activity of the c-fims promoter relative to the 13-actin promoter did not clearly distinguish macrophages from nonmacrophages. The inclusion of the intron 2 sequences reduced reporter gene expression in RAW264 cells but almost completely abolished activity in MOPC.31C, L929, and Lewis lung carcinoma cells. Also shown in Fig. 9A is the comparative activity of the SV40 early promoter and enhancer in the positive control vector pGL-Control. The 1-actin promoter was slightly less active in MOPC.31C cells than in RAW264 cells and less again than in L929 and Lewis lung carcinoma cells. We have confirmed that the levels of 1-actin mRNA and the rate of transcription of the ,-actin gene in run-on transcription assays are similar in each cell population (not shown), so the expression of this construct provides some indication of transfection efficiency in each case. By contrast, pGL-Control (the SV40 early promoter) was 20-to 50-fold more active in MOPC.31C cells than in RAW264 cells, and in L929 and Lewis lung carcinoma cells, it was a further 10-fold less active. These data suggest that the SV40 enhancer contains tissue-specific cis-acting elements.
The results of the primer extension experiments in Fig. 3 are averages of two separate transfections. In both of the experiments shown, PMA and LPS induced the activity of the SV40 promoter construct (pGL2-Control) two-to fivefold but had no effect on the activity of the ,B-actin promoter, while CSF-1 had no effect on the activity of any promoter. RLU, relative light units. and 5 suggest that CSF-1, LPS, and PMA reduce c-fis mRNA levels in macrophages by blocking transcription elongation within intron 2. Figure 9B shows the effects of the three agonists on c-fins promoter activity, using the luciferase reporter constructs above. CSF-1 had no effect in transient transfections with any of the reporter plasmids, which may reflect an artifact of transient transfection. In another study, we showed that the introduction of DNA into macrophages prevents them from responding to CSF-1 with increased growth (28) and prevents induction of the CSF-1-responsive urokinase plasminogen activator promoter (27a) .
By contrast to the data obtained with the CAT reporter constructs, PMA exerted a slight inhibition of the activity of the longer (3.5-kb) c-fins promoter but had a far more marked effect on the activity of the construct containing intron 2. LPS was more selective; it caused no inhibition of the activity of the 3.5-or 0.3-kb c-fins promoter but reduced the activity of the intron-containing construct three-to fivefold. The effects of the two agents were selective. In transfections parallel to those shown in Fig. 9 , the SV40 promoter in pGL-Control was actually trans activated by LPS and PMA, whereas the P-actin promoter was relatively unaffected (not shown).
DISCUSSION
The c-fins gene in humans is closely linked to the gene encoding the platelet-derived growth factor (PDGF) receptor on chromosome 5 (20) . Exon 1, located less than 500 bp downstream of the PDGF receptor gene, is transcribed only in trophoblasts and choriocarcinomas (20, 30) . In human monocyte cell lines, transcription initiates immediately 5' of exon 2, which contains the initiation codon. Figures 1 and 2 show that the sequences of the mouse and human c-fins genes adjacent to exon 2 are conserved and that murine primary macrophages and the macrophage line RAW264 produce transcripts initiated at a cluster of transcription start sites in this region. These data are consistent with analysis of the human c-fins gene in macrophages (20) , which identified a similar diversity of transcription start sites. The presence of multiple clustered transcription starts is common in TATA-less promoters (1, 26) . The other element typically involved in specifying accurate transcription initiation is the CCAAT box, which is usually placed 50 to 90 bp upstream of the transcription start site (6) . The repeated CCAAT-like motif around 60 to 100 bp from the multiple transcription start sites of c-fins, although it does not fit the CCAAT box consensus sequences, does bind multiple DNA-binding proteins in all cell lines tested, including at least one nuclear protein that also binds the CCAAT box sequence of the ubiquitously active H2-K promoter (unpublished data).
Taken together, the transient transfection and reverse transcriptase primer extension analyses in Fig. 2, 3 , 5, 7, 8, and 9 suggest that expression of full-length c-fins mRNA in macrophages is controlled primarily by sequences in intron 2 that probably mediate tissue-specific transcription elongation. This conclusion contrasts with the claim that the homologous human c-fins promoter directs monocyte-specific expression of a CAT reporter gene in transient transfection analysis (20) . Given the substantial homology between the promoters from the two species (Fig. 1 ) and the conserved patterns of expression, it seems unlikely that this VOL. 13, 1993 contrast reflects a genuine species difference. One possibility is that the SV40 enhancer included at the 3' end of the CAT gene in the human c-fins reporter constructs (20) confers tissue specificity as well as detectability. This possibility is favored by the data in Fig. 9A , which suggest that the SV40 promoter plasmid is tissue specific. An alternative view of the regulation of c-fins during human monocyte/macrophage differentiation derives from the work of Weber et al. (32) , who suggested that the gene is controlled via differential mRNA stability. The primer extension data do not completely exclude this as an explanation for tissue specificity and the actions of LPS, PMA, and CSF-1 but argue strongly against it. c-fins transcripts were detected in nonmacrophages with exon 2 primers (A and B) and the intronic primer (F) but not with the exon 3 primer (E). Primers B and E are contiguous in the spliced c-fins mRNA, and it is difficult to envisage a degradative pathway that spares the 5' end of c-fins so rigorously. In nuclear run-on transcription assays using a full-length cDNA, we could not detect c-fins transcripts in L929 or MOPC.31C cells, whereas they were of comparable abundance to P-actin transcripts in RAW264 cells (data not shown). Furthermore, Gusella et al. (11) provided clear evidence that the down-regulation of c-fins in a murine macrophage line by LPS occurred at the level of transcript synthesis rather than mRNA stability. Hence, we strongly favor controlled transcription elongation as the explanation of the apparent presence of short c-fins transcripts in nonmacrophages and macrophages treated with LPS, PMA, and CSF-1. Control of gene expression by at the level transcription elongation has been observed in many cellular genes, including the adenosine deaminase, c-myc, c-myb, c-fos, and epidermal growth factor receptor (EGF-R) genes (see references 4, 7, 12, 19, and 27 and references therein). The EGF-R is particularly interesting since it is another member of the protein tyrosine kinase family of receptors and directs tissue-specific differentiation of a number of epithelial cell lineages. The EGF-R gene, like c-fins, is expressed from a TATA-less promoter and initiates from multiple clustered sites (12) . Promoter activity does not correlate with patterns of expression, and a major determinant of full-length mRNA production is a transcription termination site in the first intron. As with this and most other examples of transcription attenuation, we have not been able to define exactly where the attenuated transcripts end in the case of c-fins. Although the primer extension data ( Fig. 2 and 3 ) and dot blot hybridization (Fig. 6B) indicate that short transcripts are as abundant in nonmacrophages as is the full-length mRNA in macrophages, they could not be detected by Northern blotting with a cDNA or a genomic DNA probe (not shown), and no bands protected from SI nuclease were detected in nonmacrophages in the published studies of the human c-fins gene (20, 30) . Similarly, we could not detect the short transcripts in nonmacrophages by RNase protection (Fig.  6A ). In every case in which the 3' ends of attenuated transcripts have been identified, they are extremely heterogeneous (27) even when analyzed in cell-free transcription assays (16) . Since the 5' ends of the c-fins transcripts are also heterogeneous, part of the reason they cannot be detected in Northern blots or nuclease protection may be that they do not form a definable band on a gel. An additional problem influencing detection of the short transcripts by nuclease protection is the abundance of extended GC-rich inverted repeats in exon 2 and the beginning of intron 2. In fact, the mouse sequence from -70 to +110 contains 63% GC residues. GC-rich stem-loops in both DNA and RNA are remarkably stable (13) . Furthermore, there is the potential for interchain hybridization between short c-fins transcripts because of the inverted repeats. The existence of duplexes and stem-loops in short c-fins transcripts would probably reduce hybridization in nuclease protection assays, and any regions of mismatch or loop formation would not be protected from cleavage.
Those attenuators that have been characterized in prokaryotic and eukaryotic systems often contain GC-rich motifs with dyad symmetry (27) . The c-fins sequences in exon 2, early in intron 2 (Fig. 4) , and in exon 3 (mouse cDNA bp 127 to 139; 5'-CAGGGGGCCCCTG-3') clearly resemble other attenuator sequences, including those of the c-fos gene (5'-TCCCCGGCCGGGGA-3') (18), the c-myb gene (5'-GC CCCCTGTGGGC-3') (19) , and the TAR region of human immunodeficiency virus type 1 (as shown in Fig. 4) . Homologies between c-fins sequences and the c-fos and c-myb terminators may be of functional significance. The c-fos attenuator is apparently involved in the regulation of c-fos transcription elongation in macrophages (7) . c-myb is expressed in myeloid progenitor cells, and transcriptional elongation is down-regulated during myeloid differentiation (19) . There might conceivably be a link between the control of transcription elongation of c-myb and c-Jins.
In summary, we have provided evidence that tissuespecific expression of the murine c-fins gene in macrophages and its regulation by specific agonists involve sequences in intron 2 that probably control transcription elongation. Because c-fins is the receptor for the major macrophage growth and differentiation factor CSF-1, selective elongation of c-fins transcripts may be viewed as the rate-limiting event in macrophage differentiation.
